BioPharma Dive 2025년 11월 24일 FDA probes effects of Takeda rare disease drug after patient death #FDA probes #Takeda rare
Endpoints News 2025년 11월 21일 AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US #announced Friday #billion pledge
Illumina 2025년 5월 29일 Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Illumina #unveils PromoterAI #Illumina unveils